Close

Publications

Palmer, J; SHERRATT, K; Martin-Nielsen, R; Bevan, J; GIBBS, H; Group, C; FUNK, S; ABBOTT, S;
2021
Journal of Open Source Software, (2021).6 63 10.21105/joss.03290.
Supplementary material from "Interventions targeting non-symptomatic cases can be important to prevent local outbreaks: SARS-CoV-2 as a case study".
Lovell-Read, FA; FUNK, S; Obolski, U; Donnelly, CA; Thompson, RN;
2021
, The Royal Society (2021).
Real-time estimation of the time-varying transmission advantage of Omicron in England using S-Gene Target Status as a Proxy.
ABBOTT, S; Sherratt, K; FUNK, S;
2021
(2021).
PAVELKA, M; Van-Zandvoort, K; ABBOTT, S; SHERRATT, K; Majdan, M; CMMID COVID-19 working group,; Inštitút Zdravotných Analýz,; Jarčuška, P; Krajčí, M; FLASCHE, S; FUNK, S;
2021
Science (New York, N.Y.), (2021).372 6542 10.1126/science.abf9648.
Wimalasiri-Yapa, BM C R; Barrero, RA; Stassen, L; Hafner, LM; McGraw, EA; Pyke, AT; Jansen, CC; Suhrbier, A; YAKOB, L; Hu, W; Devine, GJ; Frentiu, FD;
2021
Open Biology, (2021).11 1 10.1098/rsob.200246.
Privor-Dumm, LA; Poland, GA; Barratt, J; Durrheim, DN; Deloria Knoll, M; Vasudevan, P; JIT, M; Bonvehí, PE; Bonanni, P; International Council on Adult Immunization,;
2021
Vaccine, (2021).39 37 10.1016/j.vaccine.2020.06.082.
DAVIES, NG; FLASCHE, S; JIT, M; ATKINS, KE;
2021
Science translational medicine, (2021).13 606 10.1126/scitranslmed.aaz8690.
JOMBART, T; Ghozzi, S; Schumacher, D; Taylor, TJ; LECLERC, QJ; JIT, M; FLASCHE, S; Greaves, F; Ward, T; EGGO, RM; NIGHTINGALE, E; MEAKIN, S; BRADY, OJ; Centre for Mathematical Modelling of Infectious Di,; MEDLEY, GF; Höhle, M; EDMUNDS, WJ;
2021
Philosophical transactions of the Royal Society of London. Series B, Biological sciences, (2021).376 1829 10.1098/rstb.2020.0266.